Great article. I have a question: there’s big things happening in Autism diagnosis. What do you think about digital therapeutics for autism diagnosis? I’ve come across Cognoa who is considered one of the leaders in the prescription digital therapeutics space and the only company with two prescription digital therapeutics that have BOTH been awarded Breakthrough device designation by the FDA, multiple completed randomized clinical trials and published peer-reviewed publications, a pivotal study underway in support of its upcoming de novo submission to the FDA, and over $50M in invested. How come you didn’t include Cognoa on your list?